Cargando…
Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses
INTRODUCTION: Intravenous (IV) injection of mesenchymal stem cells (MSCs) is used to treat systemic human diseases and disorders but is not routinely used in equine therapy. In horses, MSCs are isolated primarily from adipose tissue (AT) or bone marrow (BM) and used for treatment of orthopedic injur...
Autores principales: | Kol, Amir, Wood, Joshua A, Carrade Holt, Danielle D, Gillette, Jessica A, Bohannon-Worsley, Laurie K, Puchalski, Sarah M, Walker, Naomi J, Clark, Kaitlin C, Watson, Johanna L, Borjesson, Dori L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446064/ https://www.ncbi.nlm.nih.gov/pubmed/25888916 http://dx.doi.org/10.1186/s13287-015-0050-0 |
Ejemplares similares
-
Allogeneic Stem Cells Alter Gene Expression and Improve Healing of Distal Limb Wounds in Horses
por: Textor, Jamie A., et al.
Publicado: (2017) -
Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses
por: Owens, Sean D., et al.
Publicado: (2016) -
Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype
por: Clark, Kaitlin C., et al.
Publicado: (2015) -
Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses
por: Barberini, Danielle Jaqueta, et al.
Publicado: (2018) -
Horses with equine recurrent uveitis have an activated CD4+ T‐cell phenotype that can be modulated by mesenchymal stem cells in vitro
por: Saldinger, Laurel K., et al.
Publicado: (2019)